全球生物淨化市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計生物淨化市場將從 2025 年的 2.7861 億美元成長到 2034 年的 6.1164 億美元，2026 年至 2034 年的複合年成長率為 9.13%。

由於醫療保健、製藥生產和實驗室領域對感染控制的意識不斷提高，全球生物淨化市場正在成長。生物淨化系統利用氣化過氧化氫、紫外線照射和其他技術，在受控環境中去除病原體。新冠肺炎疫情顯著加速了市場需求。

關鍵促進因素包括更嚴格的監管要求、醫院加強的感染控制措施以及生物製藥生產中無塵室設施的擴建。技術創新提高了消毒系統的自動化程度、安全性和有效性。研究機構和高等級生物安全防護設施的增加也促進了市場成長。

隨著感染預防成為醫療領域的長期優先事項，未來前景依然強勁。預計該技術的應用範圍將從醫院擴展到交通運輸、公共基礎設施和食品加工行業。永續性考量和成本效益高的系統設計將影響未來的產品開發，從而確保持續創新和穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球生物淨化市場：依成分分類

• 市場分析、洞察與預測
• 裝置
• 服務
• 消耗品

第5章：全球生物淨化市場：依化學物質分類

• 市場分析、洞察與預測
• 過氧化氫
• 二氧化氯
• 過氧乙酸
• 二氧化氮

第6章：全球生物淨化市場：依類型分類

• 市場分析、洞察與預測
• 艙室消毒
• 室內消毒

第7章：全球生物淨化市場：依最終用途分類

• 市場分析、洞察與預測
• 生技公司和研究機構
• 製藥和醫療設備製造商
• 生命科學研究機構和研究組織
• 醫院和其他醫療機構
• 食品和飲料公司
• 其他

第8章 全球生物淨化市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Amira Srl
  • Clordisys Solutions Inc
  • Ecolab
  • Fedegari Autoclavi SPA
  • Howorth Air Technology Limited
  • Jce Biotechnology
  • Noxilizer Inc
  • Steris
  • Tomi Environmental Solutions Inc
  • Zhejiang Tailin Bioengineering Co. Ltd

The Bio Decontamination Market size is expected to reach USD 611.64 Million in 2034 from USD 278.61 Million (2025) growing at a CAGR of 9.13% during 2026-2034.

The global bio decontamination market has grown due to heightened awareness of infection control in healthcare, pharmaceutical manufacturing, and research laboratories. Bio decontamination systems use vaporized hydrogen peroxide, UV radiation, and other technologies to eliminate pathogens in controlled environments. The COVID-19 pandemic significantly accelerated market demand.

Drivers include stricter regulatory requirements, increased hospital-acquired infection prevention efforts, and expansion of cleanroom facilities in biopharma manufacturing. Technological innovations have improved automation, safety, and efficacy of decontamination systems. Growth in laboratory research and high-containment facilities further supports market expansion.

Future prospects remain strong as infection prevention becomes a permanent healthcare priority. Adoption will expand beyond hospitals to transportation, public infrastructure, and food processing industries. Sustainability considerations and cost-effective system designs will influence future product development, ensuring continued innovation and steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Equipment
• Services
• Consumables

By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

By Type

• Chamber Decontamination
• Room Decontamination

By End-use

• Biotech Companies & Research Organizations
• Pharmaceutical & Medical Device Manufacturers
• Life Science Laboratories & Research Organizations
• Hospital & Other Healthcare Facilities
• Food & Beverage Companies
• Others

COMPANIES PROFILED

• Amira Srl, Clordisys Solutions Inc, Ecolab, Fedegari Autoclavi SPA, Howorth Air Technology Limited, Jce Biotechnology, Noxilizer Inc, Steris, Tomi Environmental Solutions Inc, Zhejiang Tailin Bioengineering Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIO DECONTAMINATION MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIO DECONTAMINATION MARKET: BY AGENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Agent
• 5.2. Hydrogen Peroxide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chlorine Dioxide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Peracetic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nitrogen Dioxide Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIO DECONTAMINATION MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Chamber Decontamination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Room Decontamination Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIO DECONTAMINATION MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biotech Companies & Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical & Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Life Science Laboratories & Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospital & Other Healthcare Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Food & Beverage Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIO DECONTAMINATION MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Component
  • 8.2.2 By Agent
  • 8.2.3 By Type
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Component
  • 8.3.2 By Agent
  • 8.3.3 By Type
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Component
  • 8.4.2 By Agent
  • 8.4.3 By Type
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Component
  • 8.5.2 By Agent
  • 8.5.3 By Type
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Component
  • 8.6.2 By Agent
  • 8.6.3 By Type
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIO DECONTAMINATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Amira Srl
  • 10.2.2 Clordisys Solutions Inc
  • 10.2.3 Ecolab
  • 10.2.4 Fedegari Autoclavi S.P.A
  • 10.2.5 Howorth Air Technology Limited
  • 10.2.6 Jce Biotechnology
  • 10.2.7 Noxilizer Inc
  • 10.2.8 Steris
  • 10.2.9 Tomi Environmental Solutions Inc
  • 10.2.10 Zhejiang Tailin Bioengineering Co. Ltd